Loading...
Market
Will Scale Biosciences process 100 million cells with QuantumScale by end of 2024?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Official announcements from Scale Biosciences or reputable news sources
Story
Scale Biosciences Unveils $277M '100 Million Cell Challenge' with QuantumScale Technology
Aug 14, 2024, 01:56 PM
Scale Biosciences has launched a significant initiative in the field of single-cell genomics with the introduction of the '100 Million Cell Challenge'. This program, in collaboration with Ultima Genomics and NVIDIA, aims to advance research by providing substantially subsidized costs for library preparation and sequencing. Selected projects will gain early access to Scale Bio's QuantumScale, a cutting-edge single-cell RNA sequencing technology capable of processing 2 million cells per run. The initiative includes a grant program designed to support groundbreaking research in genomics. With $277 Million in new funding, the first 50M cells accepted will be highly subsidized.
View original story
Similar markets
1 additional vendor • 25%
2 additional vendors • 25%
3 additional vendors • 25%
More than 3 additional vendors • 25%
None • 25%
1-2 institutions • 25%
3-5 institutions • 25%
More than 5 institutions • 25%
Less than 10,000 • 25%
10,000 to 20,000 • 25%
20,001 to 30,000 • 25%
More than 30,000 • 25%
No additional funding • 25%
Up to $10 million • 25%
$10 million to $50 million • 25%
Over $50 million • 25%
Cost • 25%
Efficiency • 25%
Regulation • 25%
Public acceptance • 25%
